incebral 140 mg/ml gotes 50 ml
concerta 27 mg 30 comprimits alliber prolong
concerta 18 mg 30 comprimits alliber prolong
concerta 36 mg 30 comprimits alliber prolong
concerta 54 mg 30 comprimits alliber prolong
بيكالوتاميد تيڤع ١٥٠ ملغ
teva pharmaceutical indust.ltd - bicalutamide 150 mg - tablets - bicalutamide - in patients with locally advanced prostate cancer (t3-t4 any n m0 t1-t2 n+ m0) bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.